Post-earnings recap
Reported
Thu, Oct 24, 2013
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Boston Scientific's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell 6.1% in reaction, likely due to the lack of revenue information and future guidance. Investors may be cautious as they await more clarity on the company's performance outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.17 | N/A | +8.97% |
| Revenue | N/A | N/A | N/A |
Management highlighted the positive EPS surprise as a sign of resilience. However, they did not provide specific guidance for future quarters.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
The company remains focused on long-term growth strategies.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—